DELIRIUM AS A COMPLICATION OF IMIPRAMINE THERAPY IN THE AGED
MILTON KRAMER M.D.1
1 Instructor, Dept. of Psychiatry, University of Cincinnati, College of Medicine, and VA Hospital, Cincinnati, Ohio.
Tofr
nil may well have value in the treatment of depressive responses in the aged and in those with organic reactions, as Kuhn and others have suggested; but the dosage should be reduced and the patient observed for signs of delirium.